Minervaa leading provider of anti-evasion technology, today announced the release of the industry’s first Endpoint Malware Vaccination module for enterprises. As part of their ground-breaking Anti-Evasion Platform, this new tool helps simulate infection markers across enterprise endpoints to deceive malware into believing it has already infected the system. This unique approach allows Minerva’s customers to prevent infections even if other defensive capabilities were unable to block the attack.

Read article